Non-invasive health indicator monitoring system and using method thereof
US-2015201837-A1 · Jul 23, 2015 · US
US2018267331A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2018267331-A1 |
| Application number | US-201715789440-A |
| Country | US |
| Kind code | A1 |
| Filing date | Oct 20, 2017 |
| Priority date | Mar 17, 2017 |
| Publication date | Sep 20, 2018 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A contact lens containing a photonic crystal which is configured to change color depending on a concentration of an analyte in the tears of a subject. The change in color is reversible. The contact lens may be useful for monitoring the concentration of glucose in tears of a diabetic subject or a prediabetic subject.
Opening claim text (preview).
1 . A contact lens, comprising: a photonic crystal comprising: a plurality of metal nanoparticle stacks comprising metal nanoparticles, wherein the plurality of metal nanoparticle stacks are spaced such that each metal nanoparticle stack is substantially parallel to one another; and a hydrogel matrix comprising polyhydroxyethylmethacrylate; wherein the plurality of metal nanoparticle stacks is arranged within the hydrogel matrix. 2 . The contact lens of claim 1 , wherein the metal nanoparticles comprise at least one metal selected from the group consisting of silver, gold, titanium, platinum, iron, cobalt, chromium, molybdenum, vanadium, tin, nickel, and niobium. 3 . The contact lens of claim 1 , wherein each metal nanoparticle stack comprises 20-200 metal nanoparticles. 4 . The contact lens of claim 1 , wherein the photonic crystal comprises up to 100 metal nanoparticle stacks. 5 . The contact lens of claim 4 , wherein the photonic crystal comprises 3-6 metal nanoparticle stacks. 6 . The contact lens of claim 1 , wherein a distance between adjacent metal nanoparticle stacks is in a range of 140-250 nm. 7 . The contact lens of claim 1 , wherein the plurality of metal nanoparticle stacks has a tilt angle in a range of 1-30° measured from a plane of a metal nanoparticle stack to a surface plane of the photonic crystal. 8 . The contact lens of claim 1 , wherein the metal nanoparticles are substantially spherical. 9 . The contact lens of claim 1 , wherein the metal nanoparticles have an average diameter in a range of 2-20 nm. 10 . The contact lens of claim 9 , wherein the average diameter of the metal nanoparticles varies between each metal nanoparticle stack. 11 . The contact lens of claim 1 , wherein the metal nanoparticles are randomly dispersed within each metal nanoparticle stack. 12 . The contact lens of claim 1 , wherein each metal nanoparticle stack comprises metal nanoparticles of substantially uniform diameter. 13 . The contact lens of claim 1 , wherein a distance between adjacent metal nanoparticle stacks increases or decreases in response to a concentration of an analyte thereby producing a shift in a photonic band gap and a color change in the photonic crystal. 14 . The contact lens of claim 13 , wherein the shift in the photonic band gap is reversible. 15 . The contact lens of claim 13 , wherein the color change is reversible. 16 . The contact lens of claim 13 , wherein the analyte is glucose. 17 . The contact lens of claim 16 , further comprising a sensor for measuring the shift in photonic band gap. 18 . A method for detecting a glucose concentration of a subject, the method comprising: wearing the contact lens of claim 17 , thereby contacting the contact lens to tears produced by the subject; and detecting the shift in the photonic band gap. 19 . The method of claim 18 , wherein the photonic crystal changes color in response to the glucose concentration in the tears. 20 . The method of claim 18 , wherein the subject has diabetes.
for measuring glucose, e.g. by tissue impedance measurement · CPC title
Contact lenses having special fitting or structural features achieved by special materials or material structures · CPC title
Eye · CPC title
for measuring analytes not otherwise provided for, e.g. ions, cytochromes · CPC title
for measuring blood gases · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.